Announced on December 14th, Kikuë Tachibana could secure a grant from “the Herzfelder Family Foundation” issued by the Austrian Science Fund (FWF). This call addressed topics on cellular ageing, cellular diseases and malignancies with a view to…

The RNA binding protein Brain tumor (Brat) acts as a tumor suppressor in the brain of the fruit fly Drosophila, but how it prevents tumorigenesis has been unclear. The Knoblich lab has discovered that Brat controls cell fate in neural stem cell…

Scientists at IMBA have discovered that the filaments, which generate contractile forces to form a cleavage furrow during cell division, are organized as a randomly oriented network.

Long-suspected connection between female sex hormones and development of cancer identified for the first time.

CRISPR-UMI, a novel method developed at IMBA, facilitates extremely robust and sensitive screens by tracking single mutants within a population of cells

Sabrina Ladstätter (Tachibana-Konwalski group) receives Life Science Research Award by the Austrian Association for Molecular Science and Biotechnology, IMBA- alumna Beata Mierzwa (Gerlich group) awarded with Life Science PhD Award

The Penninger lab at the IMBA developed a biobank of revertible, mutant embryonic stem cells, published in the current issue of Nature. This cell bank – called Haplobank - contains over 100,000 mutated, conditional mouse embryonic stem cell lines,…

SLAMseq is an innovative sequencing method developed at IMBA that holds significant potential for research and medicine, as reported in the latest issue of the journal Nature Methods. The unique sequencing kit is now being marketed around the world…

Glycosylation is the most abundant protein modification - over half of the proteins in our cells are ‘decorated’ with glycans. These sugar structures alter protein activities in all organisms – from bacteria to human - influencing fundamental…

Researchers at the Austrian Academy of Sciences’ Institute for Molecular Biotechnology (IMBA) have discovered a means of immunising cells against the biological weapon ricin, as reported in the current issue of Cell Research.